Zaynich, a combination of Zidebactam and Cefepime, has been cleared for the treatment of complicated urinary tract infections ...

The drug has been approved for the treatment of adult patients with complicated urinary tract infections (cUTI), including ...

Wockhardt receives CDSCO approval for Zaynich (Zidebactam/Cefepime) antibiotic for complicated urinary tract infections in ...

Wockhardt shares rose 18.33% intraday to a record high of Rs 2096.45. Market cap of the firm stood at Rs 33,732 crore.

New Delhi, May 28 (PTI) Wockhardt Ltd on Thursday said it has received approval from the Central Drugs Standard Control ...

Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland, May 28, 2026 Basilea Pharmaceutica Ltd, Allschwil (SIX: ...

New Delhi, May 28 (PTI) Wockhardt Ltd on Thursday said it has received approval from the Central Drugs Standard Control Organisation (CDSCO) for import and marketing of its indigenously discovered and ...

Wockhardt Ltd on Thursday said it has received approval from the Central Drugs Standard Control Organisation (CDSCO) to market its newly developed antibiotic, Zaynich, in India.The ...

New Drug Application (NDA) for tebipenem HBr for complicated urinary tract infections (cUTI), including pyelonephritis, is under review at the ...

Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland, May 28, 2026 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting ...

Meiji Seika Pharma: Positive Results from the Phase III Integral-1 Trial of Nacubactam, a Novel β-Lactamase Inhibitor, in Complicated Urinary Tract Infections or Acute Uncomplicated Pyelonephritis ― ...

Special to The Tribune ...